HMGN5: a potential oncogene in gliomas

HMGN5/NSBP1: A new member of the HMGN protein family that affects chromatin structure and function

(2010) Mark Rochman et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

(2010) Tao Xu et al.   BMC CANCER

Regulation of chromatin structure and function By HMGN proteins

(2009) Yuri Postnikov et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Sox11 Prevents Tumorigenesis of Glioma-Initiating Cells by Inducing Neuronal Differentiation

(2009) T. Hide et al.   CANCER RESEARCH

PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A

(2009) Yi-Hong Zhou et al.   JOURNAL OF NEURO-ONCOLOGY

The Interaction of NSBP1/HMGN5 with Nucleosomes in Euchromatin Counteracts Linker Histone-Mediated Chromatin Compaction and Modulates Transcription

(2009) Mark Rochman et al.   MOLECULAR CELL

Antiangiogenic therapy in malignant gliomas

(2008) Andrew D Norden et al.   CURRENT OPINION IN ONCOLOGY

Persistent Hypomethylation in the Promoter ofNucleosomal Binding Protein1 (Nsbp1) Correlates with Overexpression ofNsbp1 in Mouse Uteri Neonatally Exposed to Diethylstilbestrol or Genistein

(2008) Wan-Yee Tang et al.   ENDOCRINOLOGY